Foslinanib disodium
| CAS No. | 1256037-62-3 | Cat. No. | BCP49041 |
| Name | Foslinanib disodium | ||
| Synonyms | TRX818 disodium;TRX-818 disodium;TRX 818 disodium; | ||
| Formula | C16H11FNNa2O6P | M. Wt | 409.22 |
| Description | Foslinanib Disodium is the disodium salt form of foslinanib, an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry activities. Upon oral administration, foslinanib targets and inhibits the formation of vasculogenic mimicry (VM; vascular mimicry). By destroying the VM channels and network, cancer cells are devoid of perfusion leading to an induction of cancer cell apoptosis and inhibition of cancer cell proliferation. VM is associated with tumor metastasis. | ||
| Pathways | Others Pathway | ||
| Targets | Others | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.